Hemics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

Hemics General Information

Description

Developer of medical imaging and inflammation assessment devices intended for rheumatoid arthritis monitoring and clinical evaluation purposes. The company develops non-invasive optical imaging systems based on patented inflammation detection technology, disease activity monitoring support, and objective visualization tools for inflammatory joint conditions, enabling rheumatologists, healthcare providers, and medical facilities to assess inflammatory status more consistently and support treatment decision-making for patients with rheumatoid arthritis.

Contact Information

Website
www.hemics.com
Formerly Known As
Akeso Medical Imaging
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Kanaaldijk 29
  • 5683 CR Best
  • Netherlands
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Devices and Supplies
Acquirer
Vertical(s)
Corporate Office
  • Kanaaldijk 29
  • 5683 CR Best
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Nov-2018 Completed Generating Revenue
3. Early Stage VC (Series B) 09-Jan-2015 Completed Startup
2. Grant 08-Jan-2014 $68.5K Completed Startup
1. Early Stage VC 20-Sep-2011 Completed Startup
To view Hemics’s complete valuation and funding history, request access »

Hemics Patents

Hemics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140132428-A1 Aeronautical safety device Active 11-Feb-2011
US-9000951-B2 Aeronautical safety device Inactive 11-Feb-2011
EP-2642910-A1 Device and method for determining a disease activity Active 26-Nov-2010
EP-2642910-B1 Device and method for determining a disease activity Active 26-Nov-2010
US-20130310697-A1 Device and method for determining a disease activity Active 26-Nov-2010 A61B5/4528
To view Hemics’s complete patent history, request access »

Hemics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hemics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brabantse Ontwikkelings Maatschappij Venture Capital Minority
DFZ Participaties Venture Capital Minority
Horizon 2020 Government
Point One Innovation Fund Venture Capital Minority
Thuja Capital Management Venture Capital Minority
To view Hemics’s complete investors history, request access »

Hemics FAQs

  • When was Hemics founded?

    Hemics was founded in 2011.

  • Where is Hemics headquartered?

    Hemics is headquartered in Best, Netherlands.

  • What is the size of Hemics?

    Hemics has 3 total employees.

  • What industry is Hemics in?

    Hemics’s primary industry is Diagnostic Equipment.

  • Is Hemics a private or public company?

    Hemics is a Private company.

  • What is Hemics’s current revenue?

    The current revenue for Hemics is .

  • Who are Hemics’s investors?

    Brabantse Ontwikkelings Maatschappij, DFZ Participaties, Horizon 2020, Point One Innovation Fund, and Thuja Capital Management have invested in Hemics.

  • When was Hemics acquired?

    Hemics was acquired on 01-Nov-2018.

  • Who acquired Hemics?

    Hemics was acquired by Demcon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process